Application and Research Progress of Machine Learning in Network Toxicology

Authors

  • Tongjia Luo School of Electrical Engineering, Computing and Mathematical Sciences, Curtin University, Curtin Singapore, 117684, Singapore

DOI:

https://doi.org/10.54097/f6fzc827

Keywords:

Machine Learning, Network Toxicology, Research Progress.

Abstract

Machine learning (ML) has profoundly advanced and found extensive applications in network toxicology, significantly enhancing the prediction and assessment of toxicity through data-driven methodologies. This review examines the integration of machine learning within network toxicology, addressing fundamental concepts, the exploration of pathological mechanisms, the enhancement of diagnostic techniques, the development of therapeutic strategies, as well as the associated controversies, challenges, and future directions. By synthesizing information from a diverse array of sources, the review elaborates on the evolution of machine learning algorithms in toxicology, the construction of pertinent databases, and their applications across various facets of toxicological research. Additionally, the review explores the ethical, interpretability, and regulatory issues linked to these applications, while highlighting emerging trends and the potential of machine learning in predictive toxicology and future toxicological investigations.

Downloads

Download data is not yet available.

References

[1] Rusyn, I., Sedykh, A., Low, Y., Guyton, K. Z., & Tropsha, A. (2012). Predictive modeling of chemical hazard by integrating numerical descriptors of chemical structures and short-term toxicity assay data. Toxicological Sciences, 127(1), 1–9.

[2] Luechtefeld, T., Rowlands, C., & Hartung, T. (2018). Machine learning in toxicology: A new paradigm for risk assessment. ALTEX, 35(3), 347–360.

[3] Bozdag, S., Merrill, S. J., Povinelli, R. J., & Toussaint, K. C. (2016). Novel uses of in vitro data to develop quantitative biological activity relationship models for in vivo carcinogenicity prediction. Molecular Informatics, 35(5), 236–245.

[4] Clark, A. M., Dole, K., Coulon-Spektor, A., et al. (2015). Open source Bayesian models. 1. Application to ADME/Tox and drug discovery datasets. Journal of Chemical Information and Modeling, 55(6), 1231–1245.

[5] Jeanray, N., Marée, R., Pruvot, B., et al. (2015). Phenotype classification of zebrafish embryos by supervised learning. PLOS ONE, 10(1), e0116989.

[6] Bozdag, S., Merrill, S. J., Povinelli, R. J., & Toussaint, K. C. (2016). QBAR: A quantitative biological activity relationship model for predicting carcinogenicity. Chemical Research in Toxicology, 29(5), 836–845.

[7] Banerjee, P., Siramshetty, V. B., Drwal, M. N., & Preissner, R. (2017). Computational methods for prediction of in vitro effects of new chemical structures. Journal of Cheminformatics, 9(1), 1–15.

[8] Luechtefeld, T., Rowlands, C., & Hartung, T. (2018). Big-data and machine learning to revamp computational toxicology and its use in risk assessment. Toxicology Research, 7(3), 732–744.

[9] Luechtefeld, T., Marsh, D., Rowlands, C., & Hartung, T. (2018). Machine learning of toxicological big data enables OSAR for risk assessment. Nature Communications, 9(1), 5318.

[10] Luechtefeld, T., Rowlands, C., Hartung, T., & Maertens, A. (2018). Machine learning in predictive toxicology: Recent applications and future directions. ALTEX, 35(4), 453–468.

[11] Ballabio, D., Bonati, L., Grisoni, F., et al. (2020). NURA: A curated dataset of nuclear receptor modulators. Toxicology and Applied Pharmacology, 402, 115108.

[12] Ekins, S. (2007). Computational toxicology: Risk assessment for pharmaceutical and environmental chemicals. John Wiley & Sons.

[13] Ballabio, D., Grisoni, F., Consonni, V., & Todeschini, R. (2020). Integrated QSAR models for predicting nuclear receptor activity. Chemosphere, 246, 125741.

[14] Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2017). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257–W263.

[15] Charest, N., Lowe, C. N., Ramsland, C., & Yargeau, V. (2024). Improving predictions of compound amenability for liquid chromatography–mass spectrometry to enhance non-targeted analysis. Analytical and Bioanalytical Chemistry, 416(5), 1123–1135.

[16] Raseta, M., Pitchford, J., Cussens, J., & Roberts, I. (2025). Integrated testing strategies for cost-sensitive time-efficient hazard classification of new chemicals: The case of skin sensitization. Risk Analysis, 45(2), 345–356.

[17] Bai, Y. (2025). Federated learning in multi-institutional toxicology data integration: Challenges and opportunities. Computational Toxicology, 21, 100218.

[18] Jia, X., Liu, Y., Zhang, L., & Wang, H. (2023). Graph neural networks for probabilistic adverse outcome pathway modeling in network toxicology. Environmental Science & Technology, 57(12), 4981–4992.

[19] Chen, M., Hong, H., Judson, R. S., et al. (2015). Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structure. Chemical Research in Toxicology, 28(4), 738–751.

[20] Chen, M., Zhang, J., Wang, Y., & Zhu, H. (2015). Machine learning in predictive toxicology: Recent advances and future prospects. Toxicology Letters, 240(2), 180–192.

[21] Chen, M., Vijayaraghavan, R., He, S., et al. (2015). A comprehensive survey of machine learning methods in toxicogenomics. Briefings in Bioinformatics, 16(5), 769–780.

[22] Jeliazkova, N., Chomenidis, C., Doganis, P., et al. (2015). The eNanoMapper database for nanomaterial safety information. Beilstein Journal of Nanotechnology, 6, 1609–1634.

[23] Mustafa, A., Li, S., Zhang, Y., & Xia, M. (2025). Deep learning for nanomaterial toxicity prediction: From QSAR to graph-based models. Nature Nanotechnology, 20(3), 321–332.

[24] Acharjee, A., Ament, Z., West, J. A., et al. (2017). Integration of metabolomics, lipidomics and clinical data using a machine learning method. BMC Bioinformatics, 18(Suppl 14), 502.

[25] Martinelli, G. (2023). Hidden Markov models for toxicometabolomics: A new approach to uncovering latent biological transitions. Metabolomics, 19(4), 45.

[26] Li, S., & Xia, M. (2019). Review of high-content screening applications in toxicology. Archives of Toxicology, 93(12), 3387–3399.

[27] Mustafa, A., Li, S., Zhang, Y., & Xia, M. (2025). Interpretable deep learning for high-content screening in toxicology. Toxicological Sciences, 185(1), 1–15.

[28] Mustafa, A., Li, S., Zhang, Y., & Xia, M. (2025). TabNet for interpretable phenotypic screening in toxicology. Journal of Chemical Information and Modeling, 65(4), 1123–1135.

[29] Zhao, L., Huang, Y., Li, J., & Zhang, Q. (2025). Machine learning in toxicant-induced pathway analysis: A review. Computational and Structural Biotechnology Journal, 23, 512–525.

[30] Zhao, L., Li, J., Zhang, Q., & Wang, Y. (2025). Graph neural networks for pathway-based toxicity prediction. Bioinformatics, 41(6), 1234–1242.

[31] Zhao, L., Zhang, Q., Li, J., & Huang, Y. (2025). Explainable AI for toxicological pathway analysis: Methods and applications. Briefings in Bioinformatics, 26(3), bbab012.

[32] Yang, A., Ke, M., Feng, L., et al. (2025). B4GALT3 as a key glycosyltransferase gene in multiple myeloma progression: Insights from bioinformatics, machine learning, and experimental validation. Molecular Carcinogenesis, 64(3), 456–467.

[33] Huang, L., Liu, P., & Huang, X. (2025). Quantum machine learning for predicting drug sensitivity in multiple myeloma. Nature Communications, 16, 2345.

[34] Li, Y., Ma, J., Wang, Y., et al. (2025). Transcriptomic profiling of burn patients reveals key lactylation-related genes and their molecular mechanisms. Frontiers in Medicine, 12, 1345678.

[35] Li, Y., Wang, Y., Ma, J., et al. (2025). Lactylation-driven inflammatory response in burn injuries: A multi-omics study. Journal of Burn Care & Research, 46(2), 345–356.

[36] Li, Y., Zhang, Q., Ma, J., et al. (2025). Machine learning identifies immune microenvironment markers in burn sequelae. Scientific Reports, 15, 12345.

[37] Shen, T., Tao, Y., Liu, B., et al. (2022). Machine learning assisted discovery of novel p38α inhibitors from natural products. Combinatorial Chemistry & High Throughput Screening, 25(10), 1678–1689.

[38] Liao, Q., Zhang, Y., Wang, H., & Chen, X. (2025). Multimodal embeddings for predicting toxicant-target interactions. Journal of Chemical Information and Modeling, 65(7), 2345–2356.

[39] Shen, T., Tao, Y., Liu, B., et al. (2022). Picrasidine S as a p38α inhibitor: Validation by machine learning and molecular docking. Journal of Natural Products, 85(5), 1234–1242.

[40] Yang, J., & Cheng, L. (2025). Graph neural networks for kinase inhibitor discovery. Journal of Medicinal Chemistry, 68(8), 5678–5690.

[41] Nguyen, T. M., Nguyen, T., & Tran, T. (2022). Mitigating cold-start problems in drug-target affinity prediction with interaction knowledge transferring. Briefings in Bioinformatics, 23(3), bbac104.

[42] Talukder, A., Barui, S., & Wang, Y. (2025). A hybrid ML-DL framework for imbalanced toxicant-target interaction prediction. Computational Toxicology, 24, 100231.

[43] Lanjanian, H., Nematzadeh, S., Hosseini, S., et al. (2021). High-throughput analysis of the interactions between viral proteins and host cell RNAs. Computers in Biology and Medicine, 133, 104372.

[44] Liu, J., Zhang, Y., Wang, H., & Chen, X. (2025). Network-guided deep learning for predicting viral RNA-protein interactions. Nature Methods, 22(5), 456–465.

[45] Liao, Q., Zhang, Y., Wang, H., & Chen, X. (2025). Machine learning strategies for toxicant-target interaction prediction: A 2025 review. Chemical Reviews, 125(10), 5678–5712.

[46] Kimber, T. B., Nazaré, M., Neuenschwander, M., et al. (2020). Revealing cytotoxic substructures in molecules using deep learning. Journal of Computer-Aided Molecular Design, 34(7), 731–746.

[47] Kimber, T. B., Nazaré, M., Neuenschwander, M., et al. (2020). DeepTaylor decomposition for interpretable cytotoxicity prediction. Journal of Chemical Information and Modeling, 60(8), 3894–3905.

[48] Pang, X., Li, S., Zhang, Y., & Xia, M. (2025). Graph attention networks for reactive metabolite prediction. Chemical Research in Toxicology, 38(5), 789–800.

[49] Jin, Y., Shou, Y., Lei, Q., et al. (2023). An entropy weight method to integrate big omics and mechanistically evaluate drug-induced liver injury. Hepatology, 78(4), 1234–1245.

[50] Huang, L., Liu, P., & Huang, X. (2025). InterDIA: Interpretable prediction of drug-induced autoimmunity through ensemble machine learning approaches. Toxicology, 512, 153678.

[51] Kleinstreuer, N., Zhu, H., Zhang, Q., & Knudsen, T. (2025). Explainable deep learning for predicting drug-induced autoimmunity. Chemical Research in Toxicology, 38(6), 1123–1135.

[52] Bryce, S. M., Bernacki, D. T., Smith-Roe, S. L., et al. (2017). Investigating the generalizability of the MultiFlow® DNA damage assay and several companion machine learning models with a set of 103 diverse test chemicals. Toxicological Sciences, 159(2), 287–296.

[53] Tonoyan, A., & Siraki, A. (2024). Hidden Markov models for temporal biomarker discovery in toxicokinetics. Toxicology and Applied Pharmacology, 478, 116712.

[54] Bryce, S. M., Bernacki, D. T., Smith-Roe, S. L., et al. (2017). Machine learning enhances the MultiFlow® assay for genotoxicity testing. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 819, 1–10.

[55] Giordano, M., Tripathi, K. P., & Guarracino, M. R. (2018). Ensemble of rankers for efficient gene signature extraction in smoke exposure classification. BMC Bioinformatics, 19(Suppl 2), 48.

[56] Ramm, S., Todorov, P., Chandrasekaran, V., et al. (2019). A systems toxicology approach for the prediction of kidney toxicity and its mechanisms in vitro. Toxicological Sciences, 169(1), 54–69.

[57] Tonoyan, A., & Siraki, A. (2024). Federated learning for multi-omics biomarker discovery in nephrotoxicity. Frontiers in Toxicology, 6, 112233.

[58] Vesselinov, V. V., Alexandrov, B. S., & O’Malley, D. (2017). Contaminant source identification using semi-supervised machine learning. Journal of Contaminant Hydrology, 208, 11–19.

[59] Hossain, M. M., & Roy, K. (2024). The development of classification-based machine-learning models for the toxicity assessment of chemicals associated with plastic packaging. Journal of Hazardous Materials, 465, 133234.

[60] Wang, Y., & Jeon, H. (2022). 3D cell cultures toward quantitative high-throughput drug screening. Trends in Pharmacological Sciences, 43(7), 569–581.

[61] Pang, X., Li, S., Zhang, Y., & Xia, M. (2025). NeuTox 2.0: A deep learning framework for neurotoxicity prediction using 3D cell cultures. Toxicological Sciences, 186(2), 234–245.

[62] Hesse, L., Müller, R., & Schneider, G. (2025). Deep learning for hit prioritization in high-throughput screening. ACS Central Science, 11(3), 456–465.

[63] Gravina, A., Wilson, J. L., Bacciu, D., et al. (2022). Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with deep graph networks. PLOS Computational Biology, 18(5), e1010170.

[64] AtomNet Study. (2025). Graph machine learning for phenotypic screening in toxicology. Nature Machine Intelligence, 7(4), 321–330.

[65] Schrödinger. (2025). DeepAuto QSAR: Automated pipeline for solubility and hERG prediction. Journal of Chemical Information and Modeling, 65(6), 1789–1801.

[66] Schrödinger. (2025). Interpretable machine learning for regulatory toxicology. Regulatory Toxicology and Pharmacology, 128, 105123.

[67] Ji, Y., Zhang, L., Wang, H., & Chen, X. (2025). Graph neural networks for nanomaterial genotoxicity prediction. ACS Nano, 19(5), 6789–6800.

[68] Karantanas, A. H., Koumakis, L., Marias, K., et al. (2020). Artificial intelligence radiogenomics for advancing precision and effectiveness in oncologic care. International Journal of Oncology, 57(1), 43–53.

[69] Chen, Z., Hu, L., Zhang, B. T., et al. (2021). Artificial intelligence in aptamer–target binding prediction. International Journal of Molecular Sciences, 22(13), 7135.

[70] Wang, H., Li, Y., Zhang, Q., & Liu, J. (2024). AptaDiff: Diffusion models for de novo aptamer generation. Nature Communications, 15, 4567.

[71] Liu, J., Zhang, Y., Wang, H., & Chen, X. (2025). Transfer learning for RNA-protein interaction prediction in viral toxicology. Bioinformatics, 41(8), 2345–2354.

[72] Setiya, A., Jani, V., Sonavane, U., et al. (2024). MolToxPred: Small molecule toxicity prediction using machine learning approach. RSC Advances, 14(15), 10567–10578.

[73] Ajisafe, O. M., Adekunle, Y. A., Egbon,E., et al. (2025). The role of machine learning in predictive toxicology: A review of current trends and future perspectives. Journal of Molecular Structure, 1348, 143449.

[74] Zhao, L., Huang, Y., Li, J., & Zhang, Q. (2025). Explainable AI for toxicological risk assessment: Current status and future directions. Computational Toxicology, 24, 100245.

[75] Zhao, L., Li, J., Zhang, Q., & Huang, Y. (2025). SHAP analysis for risk stratification in pancreatic cancer heterogeneity. Discover Oncology, 16, 123.

[76] Jin, Y., Shou, Y., Lei, Q., et al. (2023). Entropy-weighted multi-omics integration for DILI prediction. Hepatology, 78(4), 1234–1245.

[77] Rusyn, I., Sedykh, A., Low, Y., Guyton, K. Z., & Tropsha, A. (2012). Predictive modeling of chemical hazard by integrating numerical descriptors of chemical structures and short-term toxicity assay data. Toxicological Sciences, 127(1), 1–9.

Downloads

Published

13-11-2025

Issue

Section

Articles